KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medpace Holdings (MEDP) Depreciation & Amortization - Total (2016 - 2025)

Medpace Holdings (MEDP) has disclosed Depreciation & Amortization - Total for 11 consecutive years, with $6.9 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Depreciation & Amortization - Total fell 3.1% year-over-year to $6.9 million, compared with a TTM value of $27.2 million through Dec 2025, down 2.16%, and an annual FY2025 reading of $27.2 million, down 2.16% over the prior year.
  • Depreciation & Amortization - Total was $6.9 million for Q4 2025 at Medpace Holdings, up from $6.8 million in the prior quarter.
  • Across five years, Depreciation & Amortization - Total topped out at $7.2 million in Q3 2024 and bottomed at $3.8 million in Q1 2021.
  • Average Depreciation & Amortization - Total over 5 years is $5.7 million, with a median of $6.1 million recorded in 2023.
  • The sharpest move saw Depreciation & Amortization - Total skyrocketed 55.4% in 2021, then decreased 4.82% in 2025.
  • Year by year, Depreciation & Amortization - Total stood at $4.2 million in 2021, then increased by 20.9% to $5.1 million in 2022, then grew by 26.89% to $6.4 million in 2023, then rose by 11.13% to $7.1 million in 2024, then decreased by 3.1% to $6.9 million in 2025.
  • Business Quant data shows Depreciation & Amortization - Total for MEDP at $6.9 million in Q4 2025, $6.8 million in Q3 2025, and $6.8 million in Q2 2025.